InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Nurix Therapeutics, Inc.

NRIX Clue Score49
United States Fiscal year ends November CIK 0001549595 Results filed 13 Oct 2026
Add to watchlist

What the insiders did Scheduled selling only

Individual transactions

49
Insider
Date
Role
Action
Shares
Price
Amount
Houte Hans van
4 Nov 2026
Chief Financial Officer
Sold on a plan
1,469
$16.20
$23.80K
Houte Hans van
4 Nov 2026
Chief Financial Officer
Sold on a plan
3,300
$15.38
$50.76K
Christine Ring
3 Nov 2026
Chief Legal Officer
Sold on a plan
6,113
$25.83
$157.92K
Gwenn Hansen
2 Nov 2026
Chief Scientific Officer
Sold after exercise
1,452
$26.80
$38.91K
Christine Ring
2 Nov 2026
Chief Legal Officer
Sold after exercise
1,075
$26.76
$28.77K
Christine Ring
2 Nov 2026
Chief Legal Officer
Sold after exercise
9,527
$25.74
$245.22K
Gwenn Hansen
30 Oct 2026
Chief Scientific Officer
Sold after exercise
3,957
$26.28
$103.99K
Christine Ring
30 Oct 2026
Chief Legal Officer
Sold after exercise
3,957
$26.28
$103.99K
Houte Hans van
30 Oct 2026
Chief Financial Officer
Sold after exercise
2,834
$26.28
$74.47K
Gwenn Hansen
15 Oct 2026
Chief Scientific Officer
Sold after exercise
1,452
$25.00
$36.30K
Julia P Gregory
14 Oct 2026
Director
Sold after exercise
22,583
$23.40
$528.53K
Christine Ring
2 Oct 2026
Chief Legal Officer
Sold after exercise
5,786
$23.19
$134.15K
Christine Ring
2 Sep 2026
Chief Legal Officer
Sold after exercise
400
$26.64
$10.66K
Christine Ring
2 Sep 2026
Chief Legal Officer
Sold after exercise
5,387
$25.69
$138.42K
Gwenn Hansen
1 Sep 2026
Chief Scientific Officer
Sold after exercise
1,452
$25.47
$36.98K
Gwenn Hansen
5 Aug 2026
Chief Scientific Officer
Sold after exercise
4,356
$25.00
$108.90K
Houte Hans van
4 Aug 2026
Chief Financial Officer
Sold on a plan
2,967
$24.65
$73.13K
Houte Hans van
4 Aug 2026
Chief Financial Officer
Sold on a plan
1,794
$23.89
$42.86K
Gwenn Hansen
4 Aug 2026
Chief Scientific Officer
Sold on a plan
2,611
$24.64
$64.34K
Gwenn Hansen
4 Aug 2026
Chief Scientific Officer
Sold on a plan
1,500
$23.87
$35.80K
Christine Ring
3 Aug 2026
Chief Legal Officer
Sold after exercise
16,589
$23.05
$382.36K
Gwenn Hansen
30 Jul 2026
Chief Scientific Officer
Sold after exercise
3,847
$23.38
$89.95K
Christine Ring
30 Jul 2026
Chief Legal Officer
Sold after exercise
3,847
$23.38
$89.95K
Houte Hans van
30 Jul 2026
Chief Financial Officer
Sold after exercise
2,845
$23.38
$66.52K
Christine Ring
2 Jul 2026
Chief Legal Officer
Sold after exercise
11,008
$23.56
$259.37K
Christine Ring
25 Jun 2026
Chief Legal Officer
Sold after exercise
28,935
$20.06
$580.51K
Gwenn Hansen
25 Jun 2026
Chief Scientific Officer
Sold on a plan
5,394
$20.00
$107.88K
Christine Ring
2 Jun 2026
Chief Legal Officer
Sold after exercise
8,148
$16.60
$135.25K
Houte Hans van
5 May 2026
Chief Financial Officer
Sold on a plan
582
$17.18
$10.00K
Houte Hans van
5 May 2026
Chief Financial Officer
Sold on a plan
13,473
$16.58
$223.32K
Christine Ring
4 May 2026
Chief Legal Officer
Sold on a plan
8,148
$16.96
$138.21K
Christine Ring
1 May 2026
Chief Legal Officer
Sold on a plan
5,394
$16.76
$90.41K
Gwenn Hansen
30 Apr 2026
Chief Scientific Officer
Sold after exercise
3,214
$16.65
$53.50K
Christine Ring
30 Apr 2026
Chief Legal Officer
Sold after exercise
3,214
$16.65
$53.50K
Houte Hans van
30 Apr 2026
Chief Financial Officer
Sold after exercise
2,388
$16.65
$39.75K
Christine Ring
2 Apr 2026
Chief Legal Officer
Sold on a plan
8,148
$15.24
$124.15K
Christine Ring
2 Mar 2026
Chief Legal Officer
Sold on a plan
8,148
$15.44
$125.79K
Christine Ring
9 Feb 2026
Chief Legal Officer
Sold on a plan
14,261
$16.66
$237.62K
Gwenn Hansen
3 Feb 2026
Chief Scientific Officer
Exercised, kept
31,333
$0.84
$26.32K
Gwenn Hansen
30 Jan 2026
Chief Scientific Officer
Sold after exercise
98
$17.37
$1.70K
Gwenn Hansen
30 Jan 2026
Chief Scientific Officer
Sold after exercise
4,797
$16.58
$79.55K
Christine Ring
30 Jan 2026
Chief Legal Officer
Sold after exercise
88
$17.37
$1.53K
Christine Ring
30 Jan 2026
Chief Legal Officer
Sold after exercise
4,333
$16.58
$71.85K
Houte Hans van
30 Jan 2026
Chief Financial Officer
Sold after exercise
73
$17.37
$1.27K
Houte Hans van
30 Jan 2026
Chief Financial Officer
Sold after exercise
3,588
$16.58
$59.50K
Christine Ring
20 Jan 2026
Chief Legal Officer
Sold after exercise
3,760
$18.42
$69.27K
Christine Ring
18 Dec 2025
Chief Legal Officer
Sold after exercise
200
$18.56
$3.71K
Christine Ring
18 Dec 2025
Chief Legal Officer
Sold after exercise
3,560
$17.87
$63.60K
Christine Ring
24 Nov 2025
Chief Legal Officer
Sold after exercise
37,600
$17.07
$641.70K

What was left out

Form 4 filings counted 50
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 15
Sales straight out of an exercise 33
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 295,015
History held since 29 Jul 2020